Lunit collabs with AstraZeneca, secures major deal in France Lunit and AstraZeneca have partnered to develop new AI-powered digital pathology solutions that predict non-small cell lung cancer (NSCLC).
Based on a media release, their collaboration aims…
Advancing precision in lung cancer diagnostics: Lunit’s collaboration with AstraZeneca aims to transform the speed and accuracy of detecting actionable mutations in NSCLC. (Courtesy of Lunit)
What You Should Know:
– Lunit, a provider of AI…
Continue Reading
A consortium of research institutes in South Korea has been formed to promote the utilisation of AI and national supercomputers in discovering novel drugs for treating lung cancer.According to a press statement, the following organisations will…
Continue Reading
What You Should Know:
– A new cancer treatment and research era is dawning in Japan with the launch of LC-SCRUM-CD (Lung Cancer Genome Screening Project for Individualized Medicine – Clinical Development).
– The nationwide clinical…
Continue Reading
North East London Cancer Alliance is leading a project to integrate AI into cancer diagnostic pathways, with the aim of reducing the wait time for chest X-ray results for scans with significant findings from…
Continue Reading
What You Should Know:
– PrognomiQ, a healthcare company pioneering multi-omics approaches to disease detection, has secured $34M in Series D funding led by Seer, Inc., with participation from a new strategic investor and existing…
Continue Reading
What You Should Know:
– Nebraska Medicine, the clinical partner of the University of Nebraska Medical Center, achieved a nearly 6x increase in lung cancer risk assessment completion through a collaboration with CancerIQ, a best-in-class cancer-focused…
Continue Reading
AI-Powered Chest X-rays Enhance Rapid Lung Cancer Diagnosis
Artificial intelligence (AI) continues to transform healthcare, with new innovations enhancing diagnostic capabilities. A recent study presented at the 2024 World Conference on Lung Cancer by the…
What You Should Know:
– A new study presented at the International Association for the Study of Lung Cancer (IASLC) 2024 World Conference on Lung Cancer offers exciting possibilities for early lung cancer detection.
– Researchers…
Continue Reading
Introduction
Lung cancer remains one of the leading causes of cancer-related deaths worldwide, primarily due to the challenges in early detection and monitoring. However, the recent advancements in artificial intelligence (AI) are revolutionizing lung cancer…
